Mark W Bundesmann from 309 Old Evarts Ln, Mystic, CT 06355, age 56, Phone: 8604158332

7-Hetero-Bicyclo[2.2.1]-Heptanes
view source
US Patent:

20020038028, Mar 28, 2002
Filed:

Nov 21, 2001
Appl. No.:

09/988950
Inventors:

Daniel Yohannes - Groton CT, US
Mark Bundesmann - Mystic CT, US
International Classification:

C07D498/02
C07D473/00
C 07D 4 3/02
C 07D 4 1/02
US Classification:

546/118000, 544/254000, 544/255000, 544/269000, 544/333000, 544/405000, 548/453000, 548/364700, 548/266200, 548/254000, 546/119000, 546/148000, 546/176000
Abstract:

Compounds of the formula and their pharmaceutically acceptable salts, wherein R, R, Rand Rare defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders are claimed.

7-Hetero-Bicyclo[2.2.1]-Heptanes
view source
US Patent:

20030236405, Dec 25, 2003
Filed:

Feb 27, 2003
Appl. No.:

10/375630
Inventors:

Daniel Yohannes - Groton CT, US
Mark Bundesmann - Mystic CT, US
International Classification:

C07D487/02
C07D473/02
C07D451/02
US Classification:

544/236000, 544/238000, 544/268000, 544/277000, 544/333000, 546/119000, 546/125000
Abstract:

Compounds of the formula and their pharmaceutically acceptable salts, wherein R, R, Rand Rare defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders are claimed.

7-Hetero-Bicyclo[2.2.1]-Heptanes
view source
US Patent:

20020035262, Mar 21, 2002
Filed:

Nov 21, 2001
Appl. No.:

09/988949
Inventors:

Daniel Yohannes - Groton CT, US
Mark Bundesmann - Mystic CT, US
International Classification:

C07D498/02
C07D473/00
C 07D 4 3/02
US Classification:

546/118000, 544/254000, 544/255000, 544/269000, 546/119000, 544/333000, 544/405000, 546/148000, 546/176000, 546/276700, 548/254000, 548/266200, 548/364700, 548/453000
Abstract:

Compounds of the formula and their pharmaceutically acceptable salts, wherein R, R, Rand Rare defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders are claimed.